Skip to main content
Eleni Efstathiou, MD, Oncology, Portland, OR

Eleni Efstathiou MD


Physician

Join to view full profile
  • 3303 S Bond AvePortland, OR 97239

  • Phone+1 503-494-6594

  • Fax+1 503-494-5385

Dr. Efstathiou is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Athens
    University of AthensClass of 1998

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2026 - 2026
  • TX State Medical License
    TX State Medical License 2019 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2021

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A randomized study of finite abiraterone acetate (AA) plus leuprolide (LHRHa) versus LHRHa in biochemically recurrent non metastatic hormone naïve prostate cancer (M0... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Authored Content

  • M0 CPRC: Overview of Treatment Options APCCC 2022 Presentation Eleni EfstathiouAugust 2022

Press Mentions

  • Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC
    Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPCDecember 1st, 2025
  • Niraparib and Abiraterone Combination Is Beneficial in Prostate Cancer
    Niraparib and Abiraterone Combination Is Beneficial in Prostate CancerMarch 20th, 2023
  • Latest in Hormone Sensitive Prostate Cancer
    Latest in Hormone Sensitive Prostate CancerFebruary 18th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: